Posts tagged GILD


Joel Greenblatt’s Magic Formula Says No to Two Pharma Giants: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD)

Why this Wall Street hedge fund legend sold VRX and GILD?

Read more

Jason McCarthy’s Take on Gilead Sciences, Inc. (GILD) Following ASH Data

ASH data offers insight into Gilead Sciences’ lymphoma drug Yescarta; Maxim’s Jason McCarth weighs in.

Read more

Gilead Sciences, Inc. Attracts a New Bull Thanks to “Gift” of Kite

Maxim’s McCarthy now sees 27% upside potential for Gilead, impressed with management’s plans for lymphoma asset Yescarta.

Read more

Gilead Sciences, Inc. (GILD) Has More Drivers At Play Than Just Crumbling HCV Segment: J.P. Morgan

Cory Kasimov is enthusiastic on GILD’s CAR-T therapy Yescarta as well as M&A strategy.

Read more

Gilead Sciences, Inc.’s (GILD) Q3:17 Earnings Send Shares Lower

Gilead Sciences, Inc. (NASDAQ:GILD) shares fell nearly 4% in the extended session Thursday after the …

Read more

Gilead Sciences, Inc. (GILD) Takes Promising Step with NASH Asset, Cheers J.P. Morgan

Cory Kasimov: GILD’s Phase II study data may be early, but first signs speak to a well-tolerated treatment.

Read more

Analysts Chime in on Celgene Corporation (CELG) Crohn’s Dud and Gilead Sciences, Inc. (GILD) Winning FDA Nod for Yescarta

Cowen always deemed CELG’s failed drug a risky contender, welcomes GILD’s full approval for Yescarta.

Read more

‘Stock Market Wizard’ Michael Masters Puts His Money on Transenterix Inc (TRXC), Says Bye Bye to Gilead Sciences, Inc. (GILD)

Did this $4 billion fund make the right call on these two soaring biotechs?

Read more

Gilead Sciences, Inc. (GILD) Presents Phase 3 Clinical Data in HIV-1 at IDWeek 2017

Gilead Sciences, Inc. (NASDAQ:GILD) announced detailed 48-week results from a Phase 3 study (Study 1878) evaluating …

Read more

Gilead Sciences, Inc. (GILD) Obtains CFDA Approval for Sovaldi for Treatment of Chronic Hepatitis C Virus Infection

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the China Food and Drug Administration (CFDA) has approved …

Read more